AA
EPZM

ALPS Advisors’s Epizyme, Inc EPZM Stock Holding History

ALPS Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-129,409
Closed -$1.54M – 894
2020
Q3 		$1.54M Sell
129,409
-8,447
-6% -$113K 0.02% 265
2020
Q2 		$2.21M Sell
137,856
-27,719
-17% -$484K 0.03% 229
2020
Q1 		$2.57M Sell
165,575
-17,809
-10% -$382K 0.04% 188
2019
Q4 		$4.51M Buy
183,384
+1,834
+1% +$27.2K 0.04% 166
2019
Q3 		$1.87M Sell
181,550
-8,575
-5% -$108K 0.01% 215
2019
Q2 		$2.39M Buy
+190,125
New +$2.45M 0.02% 212
2018
Q4 		– Sell
-122,992
Closed -$1.3M – 972
2018
Q3 		$1.3M Buy
122,992
+22,150
+22% +$253K 0.01% 317
2018
Q2 		$1.37M Buy
100,842
+7,918
+9% +$123K 0.01% 280
2018
Q1 		$1.65M Buy
92,924
+16,151
+21% +$273K 0.01% 230
2017
Q4 		$964K Buy
76,773
+19,301
+34% +$281K 0.01% 269
2017
Q3 		$1.09M Buy
57,472
+4,797
+9% +$73.2K 0.01% 234
2017
Q2 		$795K Buy
52,675
+2,769
+6% +$41.9K 0.01% 266
2017
Q1 		$856K Sell
49,906
-5,842
-10% -$77.8K 0.01% 231
2016
Q4 		$675K Sell
55,748
-18,138
-25% -$189K 0.01% 248
2016
Q3 		$727K Sell
73,886
-6,501
-8% -$59.3K 0.01% 237
2016
Q2 		$823K Buy
+80,387
New +$896K 0.01% 213

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

ALPS Advisors's EPZM Position: Q4 2020 in Review

ALPS Advisors sold out of Epizyme, Inc (EPZM) in Q4 2020, closing a stake of 129,409 shares — an estimated $1.54M sold.

ALPS Advisors first reported a position in EPZM in Q2 2016 and held it in 16 quarters. The position peaked at $4.51M in Q4 2019. 138 funds tracked by Wall St. Rank hold EPZM as of Q4 2020.

  • ALPS Advisors reported no remaining Epizyme, Inc position as of Q4 2020 after selling out during the quarter.
  • ALPS Advisors sold 129,409 Epizyme, Inc shares in Q4 2020, an estimated $1.54M.
  • ALPS Advisors first reported a position in Epizyme, Inc in Q2 2016 and held it in 16 quarters.
  • ALPS Advisors's Epizyme, Inc position peaked at $4.51M in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2020.

Based on ALPS Advisors's 13F filing for Q4 2020, filed 3 Feb 2021.